Systematic review with meta-analysis: The impact of cancer treatments on the disease activity of inflammatory bowel diseases.
Sigrun GrimsdottirMohamed AttauabiEmilie Kristine DahlBurisch JJakob Benedict SeidelinPublished in: Journal of Crohn's & colitis (2023)
Current data indicate a high proportion of patients with IBD experiencing a flare following the start of cancer treatment. Patients with IBD were at increased risk of gastrointestinal toxicity following ICI treatment compared to those without IBD. However, cancer therapy-induced IBD flares were manageable and should not preclude appropriate cancer treatments.
Keyphrases
- disease activity
- papillary thyroid
- rheumatoid arthritis
- cancer therapy
- systemic lupus erythematosus
- ulcerative colitis
- squamous cell
- rheumatoid arthritis patients
- ankylosing spondylitis
- oxidative stress
- squamous cell carcinoma
- juvenile idiopathic arthritis
- high glucose
- lymph node metastasis
- childhood cancer
- diabetic rats
- machine learning
- big data
- electronic health record
- young adults
- combination therapy
- deep learning
- data analysis
- replacement therapy
- artificial intelligence